The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuleihan, R.
Right arrow Articles by Chatila, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuleihan, R.
Right arrow Articles by Chatila, T.

The Journal of Immunology, Vol 146, Issue 5 1661-1666, Copyright © 1991 by American Association of Immunologists


ARTICLES

Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells

R Fuleihan, W Mourad, RS Geha and T Chatila
Division of Immunology, Children's Hospital Boston, MA 02115.

The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has been demonstrated to bind to monomorphic determinants on MHC-class II molecules. In this study, we have used TSST-1 to probe the role of MHC- class II molecules in the activation and differentiation of resting human B cells. Highly purified B cells were stimulated with TSST-1, alone or in combination with PMA or with anti-human IgM antibodies (anti-mu) and the resulting B cell proliferation and Ig production were monitored. On its own, TSST-1 failed to induce B cell proliferation or Ig production. However, TSST-1 synergized with PMA and with anti-mu in inducing B cell proliferation in the absence of any added T cells or T cell factors. TSST-1 did not induce or potentiate early activation events associated with anti-mu treatment such as phosphoinositide hydrolysis and Ca2+ mobilization. Also, TSST-1 did not potentiate the capacity of anti-mu to induce the transcription of early activation genes such as c-myc. Finally, in contrast to its capacity to promote mitogen-trigered B cell proliferation, TSST-1 failed to induce the differentiation of B lymphocytes into Ig-secreting cells in the absence of added T cells. These results indicate that TSST-1 delivers a comitogenic signal to B cells via MHC-class II molecules that is distinct from signals delivered via surface mu and further strengthens the role of MHC-class II molecules as signal transducing structures.


This article has been cited by other articles:


Home page
Int ImmunolHome page
W. Stohl, D. Xu, S. Zang, K. S. Kim, L. Li, J. A. Hanson, S. A. Stohlman, C. S. David, and C. O. Jacob
In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4+ cells and human MHC class II
Int. Immunol., October 1, 2001; 13(10): 1291 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Stohl, D. H. Lynch, G. C. Starling, and P. A. Kiener
Superantigen-Driven, CD8+ T Cell-Mediated Down-Regulation: CD95 (Fas)-Dependent Down-Regulation of Human Ig Responses Despite CD95-Independent Killing of Activated B Cells
J. Immunol., October 1, 1998; 161(7): 3292 - 3298.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Stohl, J. E. Elliott, D. H. Lynch, and P. A. Kiener
CD95 (Fas)-Based, Superantigen-Dependent, CD4+ T Cell-Mediated Down-Regulation of Human In Vitro Immunoglobulin Responses
J. Immunol., June 1, 1998; 160(11): 5231 - 5238.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-P. Truman, C. Choqueux, J. Tschopp, J. Vedrenne, F. Le Deist, D. Charron, and N. Mooney
HLA Class II-Mediated Death Is Induced Via Fas/Fas Ligand Interactions in Human Splenic B Lymphocytes
Blood, March 15, 1997; 89(6): 1996 - 2007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.